John Lubel

Adj Assoc Prof

ADJUNCT ASSOCIATE PROFESSOR (RESEARCH), Gastroenterology

EmailJohn.Lubel@monash.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

8 Finished

Community Approach Targeting Cirrhosis and Hepatocellular carcinoma (CATCH) in patients living with chronic viral hepatitis
Lubel, J.
17/04/17 → 16/04/19
Project: Research
Hepatology Clinical Trials
Lubel, J.
1/01/15 → 30/12/20
Project: Research
NHMRC Equipment Grant - BD FGACSAria Fusion Cell Sorter
Davis, I., Dear, A., Gilfillan, C., Lubel, J. & McMahon, L.
National Health and Medical Research Council (NHMRC) (Australia)
5/12/14 → 31/12/15
Project: Research
A randomised, double-blind, placebo-controlled multi centre phase III study of regorafenib in patients with hepatocellular carcinoma (HCC) after sorafenib
Lubel, J.
31/05/13 → 23/10/14
Project: Research
The Renin Angiotensin System in Inflammatory Bowel Disease
Lubel, J., Angus, P., Burrell, L. M., Garg, M. & Gibson, P.
The Broad Foundations
1/03/13 → 31/03/16
Project: Research

50 Article
15 Letter
2 Comment / Debate
2 Review Article
More
- 1 Commissioned Report
- 1 Abstract

Lessons From COVID-19, ACE2, and Intestinal Inflammation: Could a Virus Trigger Chronic Intestinal Inflammation?
Hanrahan, T. P., Lubel, J. S. & Garg, M., Jan 2021, In : Clinical Gastroenterology and Hepatology. 19, 1, p. 206 1 p.
Research output: Contribution to journal › Letter › Other › peer-review

Open Access

1 Citation (Scopus)
Epidemiology and outcomes of marked elevations of alanine aminotransferase >1000 IU/L in an Australian cohort
Con, D., Buckle, A., Nicoll, A. J. & Lubel, J. S., Apr 2020, In : JGH Open. 4, 2, p. 106-112 7 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File
Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?
Garg, M., Christensen, B. & Lubel, J. S., Oct 2020, In : Gastroenterology. 159, 4, p. 1623-1624 2 p.
Research output: Contribution to journal › Letter › Other › peer-review

Open Access
File

4 Citations (Scopus)
Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?
Garg, M., Royce, S. G., Tikellis, C., Shallue, C., Batu, D., Velkoska, E., Burrell, L. M., Patel, S. K., Beswick, L., Jackson, A., Britto, K., Lukies, M., Sluka, P., Wardan, H., Hirokawa, Y., Tan, C. W., Faux, M., Burgess, A. W., Hosking, P., Monagle, S. & 3 others, Thomas, M., Gibson, P. R. & Lubel, J., 1 May 2020, In : Gut. 69, 5, p. 841-851 11 p.
Research output: Contribution to journal › Article › Research › peer-review

56 Citations (Scopus)
Letter: ACE2, IBD and COVID-19—why IBD patients may be at reduced risk of COVID-19
Prentice, R. E., Tjandra, D., Garg, M., Lubel, J. S., Fourlanos, S., Johnson, D., Al-Ani, A. & Christensen, B., 1 Oct 2020, In : Alimentary Pharmacology and Therapeutics. 52, 8, p. 1422-1423 2 p.
Research output: Contribution to journal › Letter › Other › peer-review